Longitudinal associations between adolescent psychotic experiences and depressive symptomsContrasting effects of maternal and paternal age on offspring intelligence: the clock ticks for men tooThe prevalence of psychosis in epilepsy; a systematic review and meta-analysisSchool performance in Finnish children and later development of schizophrenia: a population-based longitudinal studyCausal association between cannabis and psychosis: examination of the evidenceReduced duration mismatch negativity in adolescents with psychotic symptoms: further evidence for mismatch negativity as a possible biomarker for vulnerability to psychosis.Common versus psychopathology-specific risk factors for psychotic experiences and depression during adolescenceIncreased risk of schizophrenia from additive interaction between infant motor developmental delay and obstetric complications: evidence from a population-based longitudinal study.Associations between childhood trauma, bullying and psychotic symptoms among a school-based adolescent sample.Childhood trauma and children's emerging psychotic symptoms: A genetically sensitive longitudinal cohort study.Psychotic symptoms in adolescence index risk for suicidal behavior: findings from 2 population-based case-control clinical interview studies.A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder.Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction.The impact of adolescent cannabis use, mood disorder and lack of education on attempted suicide in young adulthood.Premorbid intellectual functioning in bipolar disorder and schizophrenia: results from a cohort study of male conscripts.Obstetric complications and schizophrenia: historical and meta-analytic review.Are screening instruments valid for psychotic-like experiences? A validation study of screening questions for psychotic-like experiences using in-depth clinical interview.Chronic adolescent exposure to Δ-9-tetrahydrocannabinol in COMT mutant mice: impact on psychosis-related and other phenotypes.Reduced P300 amplitude during retrieval on a spatial working memory task in a community sample of adolescents who report psychotic symptoms.Relationship between the COMT-Val158Met and BDNF-Val66Met polymorphisms, childhood trauma and psychotic experiences in an adolescent general population sample.Is traumatic brain injury a risk factor for schizophrenia? A meta-analysis of case-controlled population-based studies.Pathways to schizophrenia: the impact of environmental factors.Identification and characterization of prodromal risk syndromes in young adolescents in the community: a population-based clinical interview study.Chronic adolescent exposure to delta-9-tetrahydrocannabinol in COMT mutant mice: impact on indices of dopaminergic, endocannabinoid and GABAergic pathways.Differential expression of the inflammation marker IL12p40 in the at-risk mental state for psychosis: a predictor of transition to psychotic disorder?Risk for schizophrenia--broadening the concepts, pushing back the boundaries.Functional Connectivity Anomalies in Adolescents with Psychotic SymptomsThe longitudinal association between psychotic experiences, depression and suicidal behaviour in a population sample of adolescentsExposure to obstetric complications and subsequent development of bipolar disorder: Systematic review.Neurocognition in the extended psychosis phenotype: performance of a community sample of adolescents with psychotic symptoms on the MATRICS neurocognitive battery.Etiological and clinical features of childhood psychotic symptoms: results from a birth cohort.Resting-state connectivity deficits associated with impaired inhibitory control in non-treatment-seeking adolescents with psychotic symptoms.Phenotypic Manifestation of Genetic Risk for Schizophrenia During Adolescence in the General PopulationWhither the psychosis-neurosis borderline.Psychotic symptoms, functioning and coping in adolescents with mental illnessPrevalence of psychotic symptoms in childhood and adolescence: a systematic review and meta-analysis of population-based studies.Predicting risk and the emergence of schizophrenia.Perinatal and childhood risk factors for later criminality and violence in schizophrenia. Longitudinal, population-based study.Facial emotion recognition in adolescents with psychotic-like experiences: a school-based sample from the general population.Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study.
P50
Q21131957-6A3C193D-2ED5-4550-9BA1-49D206EC5CBCQ21563400-B32C1D45-113D-4786-AF3D-9C1C3848D95BQ26850318-6A21F8E5-4A0D-4BC8-8DC4-1D29017E32F5Q28143218-03B1A3F8-4E9C-4C26-8E4D-8CD6792E909AQ28241735-8E5A96B8-4F2C-4009-802C-1ADD7F6B7E4AQ30456253-C04AAFF7-DF36-4963-AF29-8E6C064F0800Q33939666-886D41CA-855E-4D34-BF11-FD0BB18DAA96Q34010877-DA134E58-0FB0-4171-8016-58BE9C559547Q34014505-C21774DB-74EF-4753-A2D1-0389C6721294Q34024315-D456860D-5F6E-4988-AD08-4345320A7082Q34308866-2864060E-95BB-494C-BB67-4DD8405E52D6Q34357602-A237B7BC-4FD8-451D-8063-45D84B6A5373Q34415424-9630BA66-8222-42C1-8759-8CBB9E8D3562Q34447140-D080ECB9-F270-4760-B590-761DC97F703EQ34456085-366B051E-C32F-4917-B57D-5970E5BC4D77Q34524766-9BEA20FE-0F32-45F3-B377-A23EEEF59B6AQ34604254-B1E272C4-3785-49FF-9EB5-D626DD73D9C4Q34660474-6CC93C15-B673-4DC9-955D-A659DC9ED29DQ34698891-A25B52BB-20DE-4F02-9AE8-1F19B846F966Q35041475-5A05A62B-65B7-483C-9B5C-6EC625514D58Q35390447-5C52E6AC-81DC-447F-B642-16EAACE5C529Q35670625-9E39F59B-6F91-4D6D-AABA-73ACD01F1CB3Q35768242-701BECB4-BDD6-4E2E-921B-BF9C2B9DE046Q35982298-AD02B6BF-CE2F-47BC-9683-DD2DD53E3113Q36138754-ED6055EE-BA60-48E5-91E0-C45A5B80C899Q36187809-61CA2E8B-79AA-41E0-978E-D9304384FDF8Q36260876-40348035-1257-48CC-A3E7-35C260713D20Q36303812-8679436E-3710-4D87-9FF0-37AE84814EE4Q36525593-42389E0D-C707-4610-9AB5-19AF32D8E5BCQ37131000-6CADA513-F94C-47A7-97E1-81F36AC7F35BQ37180961-000E6A7F-673E-4FD5-9001-457ED923D3D3Q37209737-CE96A194-F964-401A-BC97-BDB6EC08889DQ37258886-D305DA4A-2A17-444A-8D51-26E669998BD6Q37598270-35A21423-0CAF-4A87-ACA5-3F53AEF6A928Q37686086-AF9F46BC-0F24-4767-AEB2-9A10FF309FA1Q37973822-B1339545-C064-46B7-B429-E0525EBB8339Q38038786-5F41AF21-4F80-4D1D-9009-A74DD59F8F26Q38456551-C0E4AF17-A163-412D-B6E8-B21C25F5AFD5Q39647517-69EF9FBF-E079-40B2-BAEF-17177A3E8A90Q39680990-45D76986-1081-4CA4-AE80-999AA0650F14
P50
description
Irish psychiatrist and research scientist
@en
psichiatra irlandese
@it
psikiatra irlandarra
@eu
psiquiatra irlandesa
@ast
psiquiatra irlandesa
@ca
psiquiatra irlandesa
@es
psiquiatra irlandesa
@gl
psiquiatra irlandesa
@pt
psychiatre irlandaise
@fr
psychiatrice uit Ierland
@nl
name
Mary Cannon
@ast
Mary Cannon
@en
Mary Cannon
@en-ca
Mary Cannon
@en-gb
Mary Cannon
@es
Mary Cannon
@fr
Mary Cannon
@nl
Mary Cannon
@sl
Mary Cannon
@sq
Мэри Кэннон
@ru
type
label
Mary Cannon
@ast
Mary Cannon
@en
Mary Cannon
@en-ca
Mary Cannon
@en-gb
Mary Cannon
@es
Mary Cannon
@fr
Mary Cannon
@nl
Mary Cannon
@sl
Mary Cannon
@sq
Мэри Кэннон
@ru
prefLabel
Mary Cannon
@ast
Mary Cannon
@en
Mary Cannon
@en-ca
Mary Cannon
@en-gb
Mary Cannon
@es
Mary Cannon
@fr
Mary Cannon
@nl
Mary Cannon
@sl
Mary Cannon
@sq
Мэри Кэннон
@ru
P214
P244
P5361
P101
P1053
D-8227-2012
P106
P1695
P21
P213
0000 0004 4278 4253
P214
P244
no2014003831
P27
P31
P3829
P496
0000-0002-0910-299X
P5361
CannonMary1965-
P569
1965-06-02T00:00:00Z
2000-01-01T00:00:00Z
P734
P735
P7859
lccn-no2014003831